Rankings
▼
Calendar
CPRX Q4 2018 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$500,000
Gross Profit
-$8M
-1583.4% margin
Operating Income
-$15M
-2968.7% margin
Net Income
-$14M
-2899.9% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$60M
Total Liabilities
$10M
Stockholders' Equity
$51M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$500,000
$0
—
Gross Profit
-$8M
-$3M
-132.5%
Operating Income
-$15M
-$6M
-169.3%
Net Income
-$14M
-$5M
-169.1%
← FY 2018
All Quarters
Q1 2019 →